Ehrlich, Paul
Ehrlich, Paul: (1854-1915) Renowned German scientist and physician. Born near Breslau, Ehrlich got his start there working in the laboratory of his cousin, Carl Weigert, a pathologist who pioneered the use of aniline dyes as biological stains. Ehrlich became interested in the selectivity of these dyes. He showed that they react specifically with cells and subcellular structures and that all of these dyes can be classified as basic, acid or neutral. His classic work on the staining of granules in white blood cells helped lay the foundations of hematology and histology.
Following a bout with tuberculosis, Ehrlich developed a method for staining the bacillus that caused his disease. His method became the basis of the method still used today to stain and identify the bacillus of tuberculosis. From Ehrlich’s work also came the basis for the Gram stain for bacteria, a key technique in bacteriology.
Ehrlich did important work on immunology. He also showed that the toxin-antitoxin reaction is accelerated by heat and retarded by cold, as are all biochemical reactions. He found that the content of antitoxin in sera varied so much that it was necessary to establish a standard by which their content could be measured. This he did by using units related to a fixed and invariable standard. His method formed the basis of the future standardization of sera and many other biologic products.
Ehrlich looked for chemical agents to use against disease. His research programs were guided in part by his theory that the germicidal capability of a molecule depended on its structure, particularly its side-chains, which could bind to the disease-causing organism. Ehrlich was in search of what he called the “silver bullet.”
The most successful products of this quest were Salvarsan (1909-1910) and Neosalvarsan (1912), the most effective drugs for treating syphilis until the advent of antibiotics. There is general agreement that Paul Ehrlich was one of the great medical researchers of the 19th and early 20th centuries (and all time). In 1908 he shared the Nobel Prize in Physiology or Medicine for his work on immunology.
This Paul Ehrlich is not to be confused with Paul R. Ehrlich (1932-), the American evolutionary and population biologist.
Read Also:
- Ehlers-Danlos syndrome, dermatosparaxis type
Ehlers-Danlos syndrome, dermatosparaxis type: A genetic disorder characterized by extremely fragile and sagging skin caused by mutation in the ADAMTS2 gene. People with this form of Ehlers-Danlos syndrome have soft, doughy skin that is very fragile and bruises easily. The skin sags and wrinkles, and extra (redundant) folds of skin may be present as children […]
- Ehrlichiosis
Ehrlichiosis: An acute (abrupt onset) disease, first reported in humans in 1986, due to infection by the rickettsial agent, Ehrlichia canis. The brown dog tick, is the common vector (carrier). Ehrlichiosis is clinically similar to Rocky Mountain spotted fever with high fever, headache, malaise, and muscle pain but without a rash. Laboratory features include leukopenia […]
- Hepatic
Having to do with the liver.
- Eicosapentaenoic acid
Eicosapentaenoic acid: One of the principal omega-3 fatty acids. Abbreviated EPA. The body has a limited ability to manufacture EPA by converting the essential fatty acid, alpha-linolenic acid (ALA) which is found in flaxseed oil, canola oil or walnuts.
- Eicosanoid
Eicosanoid: A lipid mediator of inflammation derived from the 20-carbon atom arachidonic acid (20 in Greek is “eicosa”) or a similar fatty acid. The eicosanoids include the prostaglandins, prostacyclin, thromboxane, and leukotrienes.